MoneyWorks4Me

Brooks Laboratories - Quaterly Results

13 Feb 2025 Evaluate
The topline for the December 2024 quarter moved up 76.80% to Rs. 384.48 millions as compared to Rs. 217.47 millions during the year-ago period.Good  Net Profit growth of 25.48% reported above the corresponding previous quarter figure of Rs. 5.77 millions to Rs. 7.24 millioins.Operating profit surged to 19.54 millions from the corresponding previous quarter of 12.51 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 384.48 217.47 76.80 771.73 617.65 24.95 794.86 555.38 43.12
Other Income 0.97 1.55 -37.42 3.64 3.02 20.53 9.56 1.15 731.30
PBIDT 19.54 12.51 56.20 40.11 31.39 27.78 41.73 -56.99 -173.22
Interest 4.46 2.13 109.39 9.30 5.71 62.87 8.45 7.67 10.17
PBDT 15.08 10.38 45.28 30.81 25.68 19.98 33.28 -64.66 -151.47
Depreciation 7.84 4.35 80.23 16.14 13.17 22.55 17.73 17.17 3.26
PBT 7.24 6.03 20.07 14.67 12.51 17.27 15.55 -81.83 -119.00
TAX 0.00 0.26 0.00 0.00 0.26 0.00 0.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.24 5.77 25.48 14.67 12.25 19.76 15.29 -81.83 -118.69
Equity 262.47 262.47 0.00 262.47 262.47 0.00 262.47 247.03 6.25
PBIDTM(%) 5.08 5.75 -11.65 5.20 5.08 2.27 5.25 -10.26 -151.16
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..